Top

Published in:

01-02-2014 | Review

Turicella otitidis and Corynebacterium auris: 20 years on

Authors: A. von Graevenitz, G. Funke

Published in: Infection | Issue 1/2014

Abstract

Turicella otitidis and Corynebacterium auris, described as new species 20 years ago, have been isolated mainly from the external ear canal and middle ear fluid. While their taxonomic position has been clearly established, their diagnosis in the routine laboratory is difficult. The question of their pathogenic potential in otitis is still open but might be elucidated better if corynebacteria are speciated more often.

Roth RR, James WD. Microbial ecology of the skin. Annu Rev Microbiol. 1988;42:441–64.PubMedCrossRef

Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324:1190–2.PubMedCentralPubMedCrossRef

Campos A, Arias A, Betancor L, et al. Study of common aerobic flora of human cerumen. J Laryngol Otol. 1998;112:613–6.PubMed

Stroman DW, Roland PS, Dohar J, Burt W. Microbiology of normal external auditory canal. Laryngoscope. 2001;111:2054–9.PubMedCrossRef

von Graevenitz A. Revised nomenclature of Alloiococcus otitis. J Clin Microbiol. 1993;31:472.

Frank DN, Spiegelman GB, Davis W, et al. Culture-independent molecular analysis of microbial constituents of the healthy human outer ear. J Clin Microbiol. 2003;41:295–303.PubMedCentralPubMedCrossRef

Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29:304–9.PubMed

Brook I, Frazier EH, Thompson DH. Aerobic and anaerobic microbiology of external otitis. Clin Infect Dis. 1992;15:955–8.PubMedCrossRef

Simonet M, de Briel D, Boucot I, et al. Coryneform bacteria isolated from middle ear fluid. J Clin Microbiol. 1993;31:1667–8.PubMedCentralPubMed

10.

Riegel P, de Briel D, Prévost G, et al. Taxonomic study of Corynebacterium Group ANF-1 strains; proposal of Corynebacterium afermentans sp.nov, containing the subspecies C. afermentans subsp. afermentans subsp.nov. and C. afermentans subsp lipophilum subsp. nov. Int J Syst Bacteriol. 1993;43:287–92.PubMedCrossRef

11.

Funke G, Bernard KA. Coryneform gram-positive rods. In: Versalovic J, Carroll KC, Funke G et al. editors. Manual of clinical microbiology, 10th ed. Vol. 1, 2011. p 413–42.

12.

Funke G, Pfyffer GE, von Graevenitz A. A hitherto undescribed coryneform bacterium isolated from patients with otitis media. Med Microbiol Lett. 1993;2:183–90.

13.

Funke G, Stubbs S, Altwegg M, et al. Turicella otitidis gen. nov. sp. nov., a coryneform bacterium isolated from patients with otitis media. Int J Syst Bacteriol. 1994;44:270–3.PubMedCrossRef

14.

Funke G, Lawson PA, Collins MD. Heterogeneity within human-derived Center for Disease Control and Prevention(CDC) coryneform Group ANF-1-like bacteria and description of Corynebacterium auris sp.nov. Int J Syst Bacteriol. 1995;45:735–9.PubMedCrossRef

15.

Renaud FNR, Grégory A, Barreau C, et al. Identification of Turicella otitidis isolated from a patient with otorrhea associated with surgery: differentiation from Corynebacterium afermentans and Corynebacterium auris. J Clin Microbiol. 1996;34:2625–7.PubMedCentralPubMed

16.

Früh M, von Graevenitz A, Funke G. Use of second-line biochemical and susceptibility tests for the differential identification of coryneform bacteria. Clin Microbiol Infect. 1998;4:332–8.CrossRef

17.

Rennie RP, Brosnikoff C, Turnbull L, et al. Multicenter evaluation of the Vitek 2 Anaerobe and Corynebacterium identification card. J Clin Microbiol. 2008;46:2646–51.PubMedCentralPubMedCrossRef

18.

Funke G, Peters K, Aravena-Roman M. Evaluation of the RapID CB Plus system for identification of coryneform bacteria and Listeria spp. J Clin Microbiol. 1998;36:2439–42.PubMedCentralPubMed

19.

Lindenmann K, von Graevenitz A, Funke G. Evaluation of the Biolog system for the identification of asporogenous, aerobic Gram-positive rods. Med Microbiol Lett. 1995;4:287–96.

20.

Farfour E, Leto J, Barritault M, et al. Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol. 2012;50:2702–8.PubMedCentralPubMedCrossRef

21.

Bernard K. The genus Corynebacterium and other medically relevant coryneform-like bacteria. J Clin Microbiol. 2012;50:3152–8.PubMedCentralPubMedCrossRef

22.

Khamis A, Raoult D, La Scola B. rpoB gene sequencing for identification of Corynebacterium species. J Clin Microbiol. 2004;42:3925–31.PubMedCentralPubMedCrossRef

23.

Funke G, Pünter V, von Graevenitz A. Antimicrobial susceptibility patterns of some recently established coryneform bacteria. Antimicrob Agents Chemother. 1996;40:2874–8.PubMedCentralPubMed

24.

Troxler R, Funke G, von Graevenitz A, Stock I. Natural antibiotic susceptibility of recently established coryneform bacteria. Eur J Clin Microbiol Infect Dis. 2001;20:315–23.PubMed

25.

Gomes-Garces J-L, Alos J-I, Tamayo J. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria. Int J Antimicrob Agents. 2007;29:688–92.CrossRef

26.

Boumghar-Bourtchai L, Chardon H, Malbruny B, et al. Resistance to macrolides by ribosomal mutation in clinical isolates of Turicella otitidis. Int J Antimicrob Agents. 2009;34:274–7.PubMedCrossRef

27.

Lagrou K, Verhaegen J, Janssens M, et al. Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility. Diagn Microbiol Infect Dis. 1998;30:7–15.PubMedCrossRef

28.

Dana A, Fader R, Sterken D. Turicella otitidis mastoiditis in a healthy child. Pediatr Infect Dis J. 2001;20:84–5.PubMedCrossRef

29.

Jeziorski E, Marchandin H, Jean-Pierre H, et al. Turicella otitidis infection : otitis media complicated by mastoiditis. Arch Pédiatr. 2009;16:243–7.PubMedCrossRef

30.

Reynolds SJ, Behr M, McDonald J. Turicella otitidis as an unusual agent causing a posterior auricular abscess. J Clin Microbiol. 2001;39:1672–3.PubMedCentralPubMedCrossRef

31.

Fernandez Pérez A, Palop Borras B, Moreno Leon JA, et al. Cervical abscess due to Turicella otitidis. Acta otorhinolaryngol Esp. 1999;50:333–5.

32.

Loiez C, Wallet F, Fruchart A, et al. Turicella otitidis in a bacteremic child with acute lymphoblastic leukemia. Clin Microbiol Infect. 2002;8:758–9.PubMedCrossRef

33.

Holzmann D, Funke G, Linder T, Nadal D. Turicella otitidis and Corynebacterium auris do not cause otitis media with effusion in children. Pediatr Infect Dis J. 2002;21:1124–6.PubMedCrossRef

34.

Gomes-Garces JL, Alhambra A, Alos JI, et al. Acute and chronic otitis media and Turicella otitidis: a controversial association. Clin Microbiol Infect. 2004;10:854–7.CrossRef

35.

Poulter MD, Hinnebusch CJ. Turicella otitidis in a young adult with otitis externa. Infect Dis Clin Pract. 2005;13:31–2.CrossRef

36.

Geyer M, Howell-Jones R, Cunningham R, et al. Consensus of microbiology reporting of ear swab results to primary care clinicians in patients with otitis externa. Br J Biomed Sci. 2011;68:174–80.PubMed

Title: Turicella otitidis and Corynebacterium auris: 20 years on
Authors: A. von Graevenitz
G. Funke
Publication date: 01-02-2014
Publisher: Springer Berlin Heidelberg
Published in: Infection / Issue 1/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-013-0488-x

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Turicella otitidis and Corynebacterium auris: 20 years on

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis

Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors

Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): a matched prospective cohort study

Reactive haemophagocytic syndrome in a patient with adult-onset Still’s disease: beta-lactams as trigger?

Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing

Antibiotic stewardship in Germany: a cross-sectional questionnaire survey of 355 intensive care units

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page